Equities researchers at Cantor Fitzgerald started coverage on shares of MedEquities Realty Trust Inc. (NYSE:MRT) in a report released on Thursday. The brokerage set an “overweight” rating and a $14.00 price target on the financial services provider’s stock. Cantor Fitzgerald’s target price would suggest a potential upside of 21.85% from the company’s previous close.

The analysts wrote, “Post-acute care focus. MRT is focused primarily on skilled nursing, inpatient rehabilitation facilities and long-term acute care hospitals. The company’s focus was developed and is guided by senior management, which, combined, has more than 80 years of experience evaluating, lending to, and investing in, post-acute care services.””

Several other analysts have also recently issued reports on the stock. Zacks Investment Research cut shares of MedEquities Realty Trust from a “hold” rating to a “sell” rating in a research report on Wednesday, May 3rd. KeyCorp reissued a “buy” rating and issued a $13.00 price objective on shares of MedEquities Realty Trust in a research report on Friday, August 25th. One analyst has rated the stock with a sell rating, two have issued a hold rating and six have assigned a buy rating to the stock. MedEquities Realty Trust has an average rating of “Buy” and an average target price of $13.00.

MedEquities Realty Trust (NYSE MRT) opened at 11.49 on Thursday. The stock’s 50 day moving average price is $11.86 and its 200-day moving average price is $11.74. MedEquities Realty Trust has a 52 week low of $10.28 and a 52 week high of $13.06. The company has a market capitalization of $364.86 million and a PE ratio of 34.92.

TRADEMARK VIOLATION WARNING: “MedEquities Realty Trust Inc. (MRT) Now Covered by Cantor Fitzgerald” was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright legislation. The correct version of this news story can be read at https://www.thecerbatgem.com/2017/09/02/medequities-realty-trust-inc-mrt-now-covered-by-cantor-fitzgerald.html.

Hedge funds have recently bought and sold shares of the company. Stevens Capital Management LP purchased a new stake in MedEquities Realty Trust during the first quarter worth $113,000. Eqis Capital Management Inc. purchased a new stake in MedEquities Realty Trust during the second quarter worth $153,000. Raymond James Financial Services Advisors Inc. purchased a new stake in MedEquities Realty Trust during the second quarter worth $154,000. Dynamic Technology Lab Private Ltd purchased a new stake in MedEquities Realty Trust during the first quarter worth $150,000. Finally, UBS Group AG raised its stake in MedEquities Realty Trust by 190.0% in the first quarter. UBS Group AG now owns 13,504 shares of the financial services provider’s stock worth $151,000 after buying an additional 8,847 shares during the period. 92.87% of the stock is currently owned by institutional investors.

MedEquities Realty Trust Company Profile

MedEquities Realty Trust, Inc is a real estate investment trust (REIT). The Company invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company invests primarily in real estate across the acute and post-acute spectrum of care. It focuses on investing in various types of healthcare properties, including acute care hospitals; skilled nursing facilities; short-stay surgical and specialty hospitals, which focus on orthopedic, heart and other dedicated surgeries and specialty procedures; dedicated specialty hospitals, such as inpatient rehabilitation facilities, long-term acute care hospitals and facilities providing psychiatric care; physician clinics; diagnostic facilities; outpatient surgery centers, and facilities that support these services, such as medical office buildings.

Analyst Recommendations for MedEquities Realty Trust (NYSE:MRT)

Receive News & Stock Ratings for MedEquities Realty Trust Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust Inc. and related stocks with our FREE daily email newsletter.